IT1050135B - Metodo per la produzione di un preparato diagnostico sulla base di macro aggregati di albumina del siero marcati con 99 mtc. - Google Patents

Metodo per la produzione di un preparato diagnostico sulla base di macro aggregati di albumina del siero marcati con 99 mtc.

Info

Publication number
IT1050135B
IT1050135B IT24778/71A IT2477871A IT1050135B IT 1050135 B IT1050135 B IT 1050135B IT 24778/71 A IT24778/71 A IT 24778/71A IT 2477871 A IT2477871 A IT 2477871A IT 1050135 B IT1050135 B IT 1050135B
Authority
IT
Italy
Prior art keywords
serum albumin
mtc
basis
production
composition
Prior art date
Application number
IT24778/71A
Other languages
English (en)
Italian (it)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Application granted granted Critical
Publication of IT1050135B publication Critical patent/IT1050135B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT24778/71A 1970-05-22 1971-05-19 Metodo per la produzione di un preparato diagnostico sulla base di macro aggregati di albumina del siero marcati con 99 mtc. IT1050135B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR707018679A FR2088139B1 (enExample) 1970-05-22 1970-05-22

Publications (1)

Publication Number Publication Date
IT1050135B true IT1050135B (it) 1981-03-10

Family

ID=9055931

Family Applications (1)

Application Number Title Priority Date Filing Date
IT24778/71A IT1050135B (it) 1970-05-22 1971-05-19 Metodo per la produzione di un preparato diagnostico sulla base di macro aggregati di albumina del siero marcati con 99 mtc.

Country Status (11)

Country Link
US (1) US3803299A (enExample)
BE (1) BE767502A (enExample)
CA (1) CA946279A (enExample)
CH (1) CH564350A5 (enExample)
DE (1) DE2124752A1 (enExample)
DK (1) DK130205B (enExample)
FR (1) FR2088139B1 (enExample)
GB (1) GB1318813A (enExample)
IT (1) IT1050135B (enExample)
NL (1) NL7106773A (enExample)
ZA (1) ZA713185B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024233A (en) * 1972-06-05 1977-05-17 Medi-Physics, Inc. 99M-technetium labeled macroaggregated human serum albumin pharmaceutical
GB1417003A (en) * 1972-06-22 1975-12-10 Radiochemical Centre Ltd Stabilisation of fibrinogen
US4002739A (en) * 1975-02-18 1977-01-11 Warner-Lambert Company Soluble collagen
US4066742A (en) * 1977-02-14 1978-01-03 Medi-Physics, Inc. Tc-99m sulfur colloid radiopharmaceuticals
US4094965A (en) * 1977-04-01 1978-06-13 New England Nuclear Corporation Diagnostic agents containing albumin and method for making same
US4197088A (en) * 1977-09-23 1980-04-08 Akro-Medic Engineering, Inc. Method for qualitative and quantitative determination of immunological reactions
US4411518A (en) * 1977-09-23 1983-10-25 Gamma Biologicals, Inc. Apparatus for use in qualitative determination of immunological reactions
US4305922A (en) * 1978-10-04 1981-12-15 University Patents, Inc. Labeling proteins with 99m-Tc by ligand exchange
CH652599A5 (de) * 1981-08-28 1985-11-29 Solco Basel Ag Verfahren zur herstellung physiologisch abbaubarer kolloidaler, human-serumalbumin enthaltender produkte und ihre verwendung.
US5071965A (en) * 1988-07-19 1991-12-10 Mallinckrodt Medical, Inc. Novel tc-99m complexes
US5096696A (en) * 1990-02-05 1992-03-17 The Research Foundation Of State University Of New York Binding of radiolabeled albumin fragments to fibrin clots
US6706251B1 (en) 1999-03-26 2004-03-16 London Health Sciences Centre Colloid for scintigraphy
CA2370409C (en) * 1999-03-26 2009-02-03 London Health Sciences Centre Colloid for scintigraphy
US6730286B2 (en) * 2001-02-28 2004-05-04 Bracco Diagnostics, Inc. Manufacturing process to control particle size
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
CN113597532B (zh) 2019-03-14 2023-02-17 泰尔茂比司特生物技术有限公司 冻干容器填充固定装置、系统及使用方法

Also Published As

Publication number Publication date
FR2088139B1 (enExample) 1973-06-08
US3803299A (en) 1974-04-09
DK130205B (da) 1975-01-20
ZA713185B (en) 1972-01-26
BE767502A (nl) 1971-11-22
FR2088139A1 (enExample) 1972-01-07
DE2124752A1 (de) 1971-12-02
NL7106773A (enExample) 1971-11-24
CA946279A (en) 1974-04-30
DK130205C (enExample) 1975-06-16
CH564350A5 (enExample) 1975-07-31
GB1318813A (en) 1973-05-31

Similar Documents

Publication Publication Date Title
IT1050135B (it) Metodo per la produzione di un preparato diagnostico sulla base di macro aggregati di albumina del siero marcati con 99 mtc.
GB1494859A (en) Encapsulated digoxin solutions and method of preparing the same
US3872226A (en) Tc{14 99m albumin aggregates with stannous tin and denatured albumin
ZA712056B (en) Method for the preparation of charge batches
CS194154B2 (en) Method of preparing 5-fluor-2-methyl-1-/4'-methyl-sulphinyl-benzylidene/-3-indenylacetic acid
ES420922A1 (es) Procedimiento para la preparacion de 2beta,16beta-diamino-5alfa-androstanos no sustituidos en la posicion 17.
ES396456A1 (es) Procedimiento para preparar cefalosporinas.
GB857193A (en) Resin-drug compounds
EG10508A (en) Method for preparation of 5-aryl 2,3-dihydro-2,2(or 3,3)dimethyl-5h-imidazo(2,1-a)isoindol-5-ols and 2(4,4(5,5)dimethyl-2-imidazolin-2-yl)bensophenone acid addition salts used as autidepressant drug
US3787565A (en) Method of producing a diagnostic preparation on the basis of an iron complex labelled with 99m tc
GB1313165A (en) Scintigraphic preparations
IL38460A0 (en) Novel phosphoric acid esters,their preparation and their use as insecticides,acaricides and nematocides
GB1396817A (en) Diagnostic preparations comprising 99m technetium
GB1429549A (en) Bone-seeking technetium-99m complex
FR2187307B1 (enExample)
ZA715813B (en) Improvements relating to 1,2,3,6-tetrahydro-4-pyridylmethyl-carbonic acid esters,as well as the acid addition salts and quaternary ammonium compounds thereof
GB1345938A (en) Benzodiazepines and process for their manufacture
Eysselt et al. Preparation and stability of sup (99m) Tc-labelled colloidal sulphur
IT1050167B (it) Procedimento per la preparazione di glucosi i fosfato
IT949906B (it) Procedimento per la preparazione di soluzioni di nitrato di calcio ed acido fosforico prive di parti celle solide in sospensione
ZA715919B (en) Process for the preparation of prostanoic acid derivatives
GB1290468A (enExample)
EG10288A (en) Process for the production of new derivatives of indolyl-acetic acid as active substance in drugs,used for inflamation sedatives and antipyrtic
Kolyaskina Some peculiarities of lymphocytes in incubation in schizophrenic patients: II. A study of the reaction of peripheral lymphocytes to administration of tissue antigens.
SEMASHKO Status of erythropoiesis in dogs exposed to gamma irradiation in doses simulating conditions accompanying prolonged spaceflight(Effects of gamma radiation on lifetime of red blood cells and bone marrow production in dogs exposed to cobalt 60 irradiation for two and one half years)